Serine protease inhibitor Kazal type 1 (SPINK1) downregulates E‐cadherin and induces EMT of hepatoma cells to promote hepatocellular carcinoma metastasis via the MEK/ERK signaling pathway
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Digestive Diseases"
DOI: 10.1111/1751-2980.12486
Abstract: To investigate serine protease inhibitor Kazal type 1 (SPINK1) expression and its influence on the prognosis of human hepatocellular carcinoma (HCC) and to explore the underlying molecular mechanisms involved. read more here.
Keywords: protease inhibitor; type spink1; hepatocellular carcinoma; kazal type ... See more keywords